Research Article
Molecular Modeling Studies of Substituted 2,4,5-Trisubstituted Triazolinones Aryl and Nonaryl Derivatives as Angiotensin II AT1 Receptor Antagonists
Table 1
The structures of triazolinone aryl and nonaryl derivatives with their activities.
| | | S. No. | R1 | R2 | | | Training/test set |
| 1 | n-Bu | H | 22 | 1.342 | Training | 2 | n-Bu | 2-CH3 | 4.1 | 0.612 | Training | 3 | n-Bu | 2-Cl | 2.4 | 0.38 | Training | 4 | n-Bu | 2-NO2 | 0.85 | −0.07 | Training | 5 | n-Bu | 2-OCH3 | 6.6 | 0.819 | Training | 6 | n-Bu | 3-CH3 | 18 | 1.255 | Test | 7 | n-Bu | 3-Cl | 120 | 2.079 | Test | 8 | n-Bu | 3-NO2 | 43 | 1.633 | Training | 9 | n-Bu | 3-OCH3 | 15 | 1.176 | Training | 10 | n-Bu | 4-CH3 | 16 | 1.204 | Test | 11 | n-Bu | 4-Cl | 69 | 1.838 | Training | 12 | n-Bu | 4-NO2 | 80 | 1.903 | Training | 13 | n-Bu | 4-OCH3 | 5 | 0.698 | Training | 14 | n-Bu | 4-C2H5 | 27 | 1.431 | Training | 15 | n-Bu | 4-F | 21 | 1.322 | Test | 16 | n-Bu | 4-COOCH3 | 33 | 1.518 | Training | 17 | n-Bu | 2--C3H7 | 1.4 | 0.146 | Training | 18 | n-Bu | 2-Phenyl | 3.6 | 0.556 | Training | 19 | n-Bu | 2-CH2Phenyl | 11 | 1.041 | Training | 20 | n-Bu | 2-F | 7.7 | 0.886 | Training | 21 | n-Bu | 2-Br | 2 | 0.301 | Test | 22 | n-Bu | 2-CF3 | 1.2 | 0.079 | Test | 23 | n-Bu | 2-COOCH3 | 5.6 | 0.748 | Training | 24 | n-Bu | 2-COOH | 115 | 2.06 | Training | 25 | n-Bu | 2-NH2 | 100 | 2.00 | Training | 26 | n-Bu | 2-N(CH3)2 | 3.2 | 0.505 | Test | 27 | n-Bu | 2,6-Cl2 | 5.8 | 0.763 | Training | 28 | n-Bu | 2-NO2, 4-OCH3 | 0.74 | −0.1307 | Training | 29 | n-Bu | 2,3,4,5,6-F5 | 17 | 1.230 | Training | 30 | n-Pr | 2-Cl | 14 | 1.146 | Test | 31 | n-Pentyl | 2-Cl | 5.7 | 0.755 | Training | 32 | n-Pr | 2-NO2 | 9.5 | 0.977 | Test | 33 | n-Pentyl | 2-NO2 | 0.93 | −0.0315 | Training | 34 | n-Bu | 2-pyridyl | 79 | 1.897 | Training | 35 | n-Bu | H | 60 | 1.778 | Training | 36 | n-Bu | CH3 | 70 | 1.845 | Test | 37 | n-Bu | C2H5 | 10 | 1.000 | Training | 38 | n-Bu | C3H7 | 8.2 | 0.913 | Training | 39 | n-Bu | C4H9 | 2.9 | 0.462 | Test | 40 | n-Bu | -propyl | 7.7 | 0.886 | Training | 41 | n-Bu | -butyl | 3.2 | 0.505 | Test | 42 | n-Bu | -butyl | 1.8 | 0.255 | Training | 43 | n-Bu | CH2COOCH3 | 17 | 1.23 | Training | 44 | n-Bu | Benzyl | 4.6 | 0.662 | Test | 45 | n-Bu | CH2 (c-Hexane) | 2.9 | 0.462 | Training | 46 | n-Bu | (2-CH3) benzyl | 11 | 1.401 | Test | 47 | n-Bu | (3-CH3) benzyl | 12 | 1.079 | Training | 48 | n-Bu | (α-CH3) benzyl | 4.9 | 0.69 | Training | 49 | n-Bu | (2-COOCH3) benzyl | 11 | 1.041 | Test | 50 | n-Bu | (3-COOCH3) benzyl | 110 | 2.041 | Training | 51 | n-Bu | (4-COOCH3) benzyl | 23 | 1.361 | Training | 52 | n-Bu | (α-COOCH3) benzyl | 12 | 1.079 | Training | 53 | n-Bu | (2-COOH) benzyl | 490 | 2.690 | Training | 54 | n-Bu | (α-COOH) benzyl | 68 | 1.832 | Training | 55 | n-Bu | CH2C6F6 | 6 | 1.505 | Training |
|
|
aIC50 or inhibition of specific binding of [125I-rabbit aorta Ang II AT1 receptor.
b−log IC50 to generate equation.
|